http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110776409-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-481
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C46-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C50-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C46-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2019-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2022-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2022-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-110776409-B
titleOfInvention A kind of extraction method of Indian Dalbergia and application of the extract in antitumor drugs
abstract The invention relates to a method for extracting Indian Dalbergia, which is Leguminosae Dalbergia Dalbergia plant Dalbergia sissoo Roxb.; the extract comprises alcohol extract, ether extract and petroleum ether extract; The isolated monomer is 4-Methoxydalbergione. Specifically comprising the following steps: taking the heartwood of Indian Dalbergia, slicing it into thin slices, pulverizing and passing through a No. 2 sieve, the extraction solvent is ethanol or methanol solution, the material-to-liquid ratio is 1:2-1:8, heating and refluxing extraction 2-5 times, 1‑3h each time. Filter while hot, combine the filtrates, and concentrate under reduced pressure to form a dilute extract. It has been confirmed by cell experiments that Dalbergia indica has important medicinal value. Its monomer can significantly inhibit the proliferation of human hepatoma cells HepG2, human breast cancer cells MCF-7, mouse breast cancer cells 4T1 and human glioma cells U87, and affect their morphological functions. It will provide a basis for the development and utilization of Indian Dalbergia, and provide new options for the research and development of anti-tumor drugs.
priorityDate 2019-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35048
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP70059
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9833444
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35049
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35050
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35051
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19799
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44516816
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419525085
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00761
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID30771
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO97399
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00764
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419522783
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP51588
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00775
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394722
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4650
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP24664
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426149775
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP83348
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP23916
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538188
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ59149
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81071
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35034

Total number of triples: 46.